Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1069 of 1,261
  1. US 7323334

    Screening and therapeutic methods relating to neurogenesis

    The Regents of the University of California · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  2. US 7320990

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted
  3. US 7320965

    Compositions and methods for inhibiting expression of Huntingtin gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted
  4. US 7321063

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted
  5. US 7321065

    Thyronamine derivatives and analogs and methods of use thereof

    The Regents of the University of California · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted
  6. US 7320991

    Analogs of thalidomide as potential angiogenesis inhibitors

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted
  7. US 7320783

    Methods and compositions for the enhancement of wound healing

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted
  8. AU 2007271920

    Benzyl amines, a process for their production and their use as anti-inflammatory agents

    BAYER SCHERING PHARMA AG [SE] · Granted Jan 17, 2008 · Expires Jan 12, 2028

    granted
  9. US 7319171

    Sertraline hydrochloride form II and methods for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted
  10. US 7319091

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted
  11. US 7318861

    Effect pigment

    BASF CATALYSTS LLC · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted
  12. US 7319015

    Methods and compositions for using alveolar macrophage phospholipase A2

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted
  13. US 7319000

    Compositions and methods for eliciting immune or anti-infective responses

    The Board of Regents of the University of Texas System · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted
  14. US 7319134

    Regulation of transcription factor, NF-IL6/LAP

    The Regents of the University of California · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted
  15. US 7317086

    Basal cell carcinoma tumor suppressor protein

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted
  16. US 7316811

    Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted
  17. US 7317022

    Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists

    Theravance, Inc. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted
  18. US 7317023

    Diaryl ether β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted
  19. US 7317127

    Process for the optical resolution and recycling of tomoxetine

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted
  20. US 7317020

    Isolation and structure of Cribrostatin 6

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted
  21. US 7317102

    Diarylmethyl and related compounds

    Theravance, Inc. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted
  22. CA 2653382

    COMPOSITION STABILISEE COMPRENANT DES INHIBITEURS DE L'ECA

    ALPHAPHARM PTY LTD [AU] · Granted Jan 3, 2008 · Expires Dec 29, 2027

    granted
  23. US 7314625

    Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences

    The United States as represented by the Secretary of the Department of Health and Human Services · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted
  24. US 7314624

    Nanoemulsion vaccines

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.